Sunlenca Product Label
Interaction Color Code
Clinical Bottom Line
Administer standard doses
Drug 1
Drug 1 dose
300 mg orally x 1
Drug 1 effect
AUC increased 41%; Cmax increased 9%
Drug 2
Drug 2 dose
400 mg BID x 2 days then 200 mg BID
Drug 2 effect
Not reported
Mechanism
Inhibition of CYP3A4 by voriconazole
Clinical Effects
No clinically significant effect expected
Info Source
